Association of Serum Calprotectin and the C-Reactive Protein–Triglyceride–Glucose Index with SYNTAX Score in Patients with Newly Diagnosed Coronary Artery Disease
Open Access
Abstract
Background and Objectives: Systemic inflammation is a key driver in the progression and complexity of coronary artery disease (CAD). Serum calprotectin and the C-reactive protein–triglyceride–glucose index (CTI) have emerged as potential inflammatory and metabolic biomarkers; however, their association with angiographic disease severity has not been clearly defined. This study aimed to evaluate the relationship between serum calprotectin, CTI, and the SYNTAX score (SS) in patients with stable CAD. Materials and Methods: A total of 134 patients undergoing coronary angiography were enrolled. The SS was calculated to quantify coronary lesion complexity. Patients were classified into two groups based on the results of the coronary angiogram: low SS (n = 73, SS < 23), and intermediate–high SS (n = 61, SS ≥ 23). Serum calprotectin, and CTI were obtained at baseline. Correlation analyses were performed to evaluate associations between biomarkers and SS. Receiver operating characteristic (ROC) curve analysis assessed the ability of these biomarkers to predict intermediate–high SS. Univariable and multivariable logistic regression analyses were performed to determine independent associations. Results: Patients with intermediate–high SS had significantly higher levels of serum calprotectin (1009.5 vs. 505.7 ng/mL), and CTI (9.9 vs. 9.5) compared with those with low SS (all p < 0.001). Spearman correlation analysis demonstrated significant positive correlations between SS and, serum calprotectin (ρ = 0.488), and CTI (ρ = 0.453) (all p < 0.001). ROC analysis showed moderate association in respect to intermediate–high SS (0.739 for serum calprotectin, and 0.722 for CTI). In multivariable models, CTI showed the strongest independent association with intermediate–high SS (OR: 4.66, 95% CI: 2.00–10.84, p < 0.001). Conclusions: Serum calprotectin and CTI were significantly associated with coronary lesion complexity, as measured by the SS. These biomarkers may serve as valuable tools for identifying patients with greater CAD severity and anatomical complexity.Keywords
All Related Versions
This publication has 25 references indexed in Scilit:
- Association between C-reactive protein-triglyceride glucose index (CTI) and cardiovascular and all-cause mortality risk among the elderly population: insights from three datasetsClinical Research in Cardiology, 2026
- C-reactive protein–triglyceride glucose index in predicting three-vessel coronary artery disease risk: a retrospective study using machine learning approachesAnnals of Medicine, 2025
- Association between C-reactive protein-triglyceride glucose index and Future cardiovascular disease risk in a population with cardiovascular-Kidney-metabolic syndrome stage 0–3Scientific Reports, 2025
- Revascularization in Stable Coronary Disease: A Systematic Review and Meta-Analysis of Randomized Clinical TrialsInternational Journal of Angiology, 2025
- Epidemiological and Translational Study of Calprotectin and Atherosclerotic Cardiovascular DiseaseJAMA Cardiology, 2025
- Treatment recommendation based on SYNTAX score 2020 derived from coronary computed tomography angiography and invasive coronary angiographyThe International Journal of Cardiovascular Imaging, 2023
- SYNTAX Score and Long-Term OutcomesJACC, 2017
- Optimal revascularization for complex coronary artery diseaseNature Reviews Cardiology, 2013
- C-Reactive Protein and the Prediction of Cardiovascular Events Among Those at Intermediate RiskJACC, 2007
- Inflammation in atherosclerosisNature, 2002